Biogenea Pharmaceuticals Ltd.
Clinical trials sponsored by Biogenea Pharmaceuticals Ltd., explained in plain language.
-
AI-Designed cancer vaccine enters human testing for colorectal cancer
⭐️ VACCINE ⭐️ Recruiting nowThis early-phase trial tests a personalized vaccine called COLONYVAQ-CRC, designed using AI and quantum physics, for patients with stage III colorectal cancer that has been surgically removed. The vaccine is given alongside standard chemotherapy and an immunotherapy drug (nivolum…
Phase: EARLY_PHASE1 • Sponsor: Biogenea Pharmaceuticals Ltd. • Aim: ⭐️ VACCINE ⭐️
Last updated Jun 27, 2026 08:09 UTC
-
AI-Designed vaccine takes on deadly brain cancer in first human trial
Disease control Recruiting nowThis early-phase trial tests a personalized vaccine called Tamavaq NeoVaccine in 29 adults with newly diagnosed glioma, a type of brain cancer. The vaccine is custom-made for each patient using AI and quantum mechanics to target unique cancer markers. The main goal is to check if…
Phase: EARLY_PHASE1 • Sponsor: Biogenea Pharmaceuticals Ltd. • Aim: Disease control
Last updated Jun 27, 2026 08:03 UTC